94 related articles for article (PubMed ID: 6687560)
1. Phase II study of AMSA in refractory testicular cancer.
Williams SD; Duncan P; Einhorn LH
Cancer Treat Rep; 1983 Mar; 67(3):309-10. PubMed ID: 6687560
[No Abstract] [Full Text] [Related]
2. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer.
Tannir N; Spitzer G; Schell F; Legha S; Zander A; Blumenschein G
Cancer Treat Rep; 1983 Jun; 67(6):599-600. PubMed ID: 6344995
[No Abstract] [Full Text] [Related]
4. Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
Natale RB; Yagoda A; Blumenreich MS; Watson RC
Cancer Treat Rep; 1983 Apr; 67(4):391-2. PubMed ID: 6687836
[No Abstract] [Full Text] [Related]
5. Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study.
Amrein PC; Coleman M; Richards F; Poulin RF; Bernhardt B; Ginsberg SJ; Green MR; Morrison A; Cortes E; Kiang D; Weinberg V; Wood WC
Cancer Treat Rep; 1982 May; 66(5):1211-3. PubMed ID: 6896294
[No Abstract] [Full Text] [Related]
6. Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
Fuks JZ; Van Echo DA; Aisner J; Von Hoff D; Wiernik PH
Cancer Treat Rep; 1981; 65(1-2):133-4. PubMed ID: 6261947
[No Abstract] [Full Text] [Related]
7. M-AMSA in disseminated prostatic carcinoma: a phase II study.
Drelichman A; Decker DA; Al-Sarraf M; Dhabuwala CB
Cancer Treat Rep; 1982 Nov; 66(11):1993-4. PubMed ID: 6897206
[No Abstract] [Full Text] [Related]
8. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
Currie VE; Howard J; Wittes R
Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced colorectal carcinoma with AMSA.
Ferraro JA; Horton J; Weissman C; Ruckdeschel JC; O'Donnell M; Ludlum D
Cancer Treat Rep; 1981; 65(3-4):345-7. PubMed ID: 6894563
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of AMSA in refractory breast cancer.
De Lena M; Rossi A; Bonadonna G
Cancer Treat Rep; 1982 Feb; 66(2):403-4. PubMed ID: 6895717
[No Abstract] [Full Text] [Related]
11. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.
Schneider RJ; Woodcock TM; Yagoda A
Cancer Treat Rep; 1980 Jan; 64(1):183-5. PubMed ID: 6892892
[No Abstract] [Full Text] [Related]
12. Phase II study of amsacrine (AMSA) in previously treated patients with advanced transitional cell carcinoma of the urothelium: a National Bladder Cancer Collaborative Group A study.
Trump DL; Loening S; Ahmed SW; Wajsman Z
Cancer Treat Rep; 1983 Sep; 67(9):845-6. PubMed ID: 6688377
[No Abstract] [Full Text] [Related]
13. Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study.
Ahmann FR; Meyskens FL; Jones SE; Bukowski RM; Saiers JH; Ryan DH; Costanzi J; Vaughn CB; Coltman CA
Cancer Treat Rep; 1983; 67(7-8):697-700. PubMed ID: 6688199
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
Amrein PC; Richards F; Coleman M; Poulin RF; Holland JF; Weinberg V; Perry M
Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510
[No Abstract] [Full Text] [Related]
15. Phase II evaluation of AMSA in patients with metastatic lung cancer.
Nichols WC; Eagan RT; Frytak S; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1980; 64(12):1383-5. PubMed ID: 6894104
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of AMSA in prostatic cancer.
Natale RB; Yagofa A; Watson RC
Cancer Treat Rep; 1982 Jan; 66(1):208-9. PubMed ID: 6895482
[No Abstract] [Full Text] [Related]
17. Phase II study of AMSA in patients with advanced ovarian cancer.
Kearsley JH; Coates AS; Fox RM; Tattersall MH; Page J; Levi JA
Cancer Treat Rep; 1982 May; 66(5):1242-3. PubMed ID: 6896295
[No Abstract] [Full Text] [Related]
18. Phase II trial of AMSA in previously treated patients with stage III and IV ovarian cancer.
Schneider RJ; Woodcock TM; Howerd J; Ochoa M
Cancer Treat Rep; 1982 Jul; 66(7):1589-90. PubMed ID: 6896470
[No Abstract] [Full Text] [Related]
19. Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
Casper ES; Gralla RJ; Kelsen DP; Natale RB; Sordillo P; Houghton A
Cancer Treat Rep; 1980; 64(2-3):345-7. PubMed ID: 6893294
[No Abstract] [Full Text] [Related]
20. Phase II clinical trial of 4'-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in the treatment of advanced non-Hodgkin's lymphomas.
Abate G; Villari P; Comella P; D'Aprile M; Castello G; Silvestro P; Zarrilli D; Pergola M
Haematologica; 1985; 70(1):35-8. PubMed ID: 3924754
[No Abstract] [Full Text] [Related]
[Next] [New Search]